2026 Asia International Medical Devices, Supplies & Laboratory Exhibition: Focusing on Thailand, Co‑Creating New Opportunities for ASEAN Healthcare

The 2026 Asia International Medical Devices and Supplies & Laboratory Exhibition (WHX Bangkok & WHX Labs Bangkok) will be held on… July 8–10, 2026 In Bangkok, Thailand Held. This edition of the exhibition is organized by Informa Exhibitions, It is one of the most influential international trade shows in Southeast Asia for medical devices and laboratory equipment. Held annually, the exhibition adopts a touring format, alternating between Malaysia and Thailand, with the aim of providing a sustainable platform for exchange and development within the Asia-Pacific healthcare industry.

The exhibition covers three major sectors—medical devices, home healthcare, and laboratory diagnostics—showcasing cutting-edge products and services such as medical electronic instruments, imaging equipment, diagnostic reagents, rehabilitation aids, and digital health technologies. The event is dedicated to establishing a platform for cross‑industry dialogue across the entire medical value chain, fostering the integration of resources and technological collaboration in the Asia‑Pacific region.

In 2025, the exhibition was successfully held in Malaysia, attracting participants from 54 Multiple countries and regions 450 Among the participating enterprises, more than 10,000 visits. During the exhibition, a series of events were held 60 A series of specialized conferences and forums focused on hot topics such as AI-driven healthcare applications, telemedicine, and cross-border procurement, offering exhibitors and attendees in-depth industry insights and opportunities for collaboration.

Thailand is situated at the geographical heart of Southeast Asia, serving as a “crossroads” that connects China, India, and the ASEAN member states. Its strategic location makes it easily accessible to exhibitors and professional buyers from around the world. With political stability, Thailand offers a favorable business environment and robust legal protections for foreign-invested enterprises. English is widely spoken—more than 80% of the population uses it—greatly facilitating international business communication. The Thai government’s “Thailand 4.0” strategy aims to drive economic structural transformation; in particular, the Eastern Economic Corridor (EEC), a national-level initiative, has already attracted over US$30 billion in investment, with a focus on cutting-edge sectors such as automation and robotics, as well as aerospace.

Thailand has become a global benchmark for medical tourism, thanks to its “high cost-effectiveness plus international-standard services” model, attracting a large number of international patients seeking cutting-edge treatments in anti-aging, orthopedics, cardiovascular care, and other specialized fields. In 2024, the total size of Thailand’s medical tourism market surpassed 50 billion Thai baht (approximately US$1.43 billion), directly boosting demand for high-end medical devices and digital health services. According to government data, in 2023, Thailand ranked fourth worldwide in medical tourism revenue. By 2025, the country’s healthcare industry is projected to generate economic value of 690 billion Thai baht, contributing 3.39% to Thailand’s GDP.

The Thai government has launched the “Healthcare Hub 4.0” strategy, an integral component of the national “Thailand 4.0” initiative, with the aim of transforming Thailand from a low-cost healthcare provider into a premier ASEAN hub for advanced medical services and digital health. The strategy prioritizes the research, development, and implementation of digital health technologies such as AI‑driven diagnostics, telemedicine, and wearable devices. Additionally, the government has approved the “Thailand International Healthcare Hub Strategy 2025–2034,” which seeks to strengthen Thailand’s healthcare ecosystem across four key pillars—health promotion services, clinical care, academic research, and pharmaceuticals and health products—thereby enhancing the global competitiveness of Thailand’s health‑care sector.

As a leading healthcare hub within ASEAN, Thailand’s medical tourism industry enjoys a strong international reputation. In recent years, private hospitals in the country have seen steadily increasing demand for cutting-edge medical equipment, such as minimally invasive surgical instruments and advanced imaging diagnostic systems. According to statistics, Thailand boasts a sizable healthcare infrastructure, with private institutions accounting for the majority of services. Supported by government initiatives to upgrade the health sector, the medical and healthcare industry is projected to contribute 5% of Thailand’s GDP by 2035.

The Thai medical device market is characterized by a pronounced dual pattern of heavy import dependence and distinctive export strengths. Import dependency stands at approximately 90%, with the main source countries being the United States (29%), Japan (17%), China (15%), and Germany (14%). In contrast, Thailand’s domestic medical device industry is dominated by low‑value consumables such as disposable syringes, infusion sets, and catheters, which account for a substantial share of the country’s medical device export value.

The Thai government, through the Board of Investment (BOI), is implementing investment promotion policies to actively encourage the localization of high-value-added medical products. This policy direction presents promising development opportunities for relevant enterprises.

By 2025, individuals aged 60 and above will account for 22% of Thailand’s total population, accelerating the country’s transition into an aging society. This demographic shift underscores substantial market potential in chronic disease management, home-based rehabilitation, and elderly‑care medical devices. Furthermore, from 2025 to 2027, the domestic distribution value of pharmaceutical products in Thailand is projected to grow at an annual rate of 6.0%–7.0%.

The ASEAN digital healthcare market is projected to surpass US$5 billion by 2029. Launched in January 2025, the China–ASEAN Regional Pharmaceutical Joint Procurement Platform has significantly lowered the barriers for Chinese companies entering the ASEAN market through collaborative purchasing and mutual recognition of standards. As the geographical center of ASEAN, Thailand has emerged as a strategic hub for Chinese enterprises seeking to tap into a regional market of 650 million consumers.

WHX Bangkok & WHX Labs Bangkok 2026 Project ordering has been fully launched, Premium booths available on a first-come, first-served basis.